Definitive Contract 75N91018C00043
Award Date
9/22/18
Potential Completion Date
3/21/24
Potential Value
$16M
Federal Agency
National Cancer Institute
Awardee
Westat, Inc.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $16,784,848.00 cost-plus-fixed-fee definitive contract awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services, to Westat, Inc., a prominent professional services firm. The contract is for support services related to studies of infection, immunity, and cancer, and has a period of performance through July 5, 2024. Westat has extensive experience supporting federal agencies, including the NCI, across a range of public health, research,...
This is a $8,525,918.00 cost-plus-fixed-fee definitive contract awarded by the National Cancer Institute (NCI), a civilian agency, to Westat, Inc. for support services for the Metabolic Epidemiology Branch. The contract has a period of performance ending on June 30, 2024. Westat is a prominent professional services firm that provides research, technical assistance, program support, data collection, analysis, and evaluation services to federal agencies. The contract does not have a small business...
This is a $65,127,025.00 cost-plus-fixed-fee definitive contract awarded by the National Cancer Institute (NCI) to Westat, Inc., a professional services firm. The contract is for clinical genetics branch support services, including services such as site study setup, protocol writing, and electronic patient-reported outcomes collection for cancer clinical trials. Westat has extensive experience providing research, technical assistance, and program support services to federal agencies,...
This is a federal contract award to Westat, Inc., a professional services firm, by the National Cancer Institute (NCI), a civilian agency under the Department of Health and Human Services. The $10,071,871.00 cost-plus-fixed-fee contract is for biomedical (applied/exploratory) services and has a completion date of September 29, 2005. The contract is not set aside. Westat has extensive experience providing research, technical assistance, and program support services to various federal agencies,...
This is a definitive contract awarded by the National Cancer Institute, part of the Department of Health and Human Services, to Westat, Inc., a for-profit professional services firm. The contract, valued at $18,272,174.00, is for developmental and technical services to support the Risk Factor Monitoring and Methods Branch. The contract does not have a set-aside designation. Westat has a history of providing a wide range of services to federal agencies, including survey research, data...
This federal contract award, valued at $41,827,930.94, was issued by the National Cancer Institute (NCI) to Westat, Inc., a prominent professional services firm based in Rockville, Maryland. The contract, which has no set-aside designation, is for the "DEVELOPMENT AND TECHNICAL SERVICES FOR THE NCI APPLIED RESEARCH PROGRAM" and has an ultimate completion date of August 31, 2014. Westat has extensive experience providing research, technical assistance, and program support services to...
This is a $21,248,975.00 cost-plus-fixed-fee delivery order contract awarded to Westat, Inc., a professional services firm in Rockville, Maryland, by the National Cancer Institute (NCI). The contract provides clinical, genetic, and epidemiological support services under the Division of Cancer Epidemiology and Genetics (DCEG) Field and Biospecimen Support Services indefinite delivery/indefinite quantity (IDIQ) contract vehicle. The contract does not have a small business set-aside designation....
This is a $32,485,777.00 cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute (NCI) to Westat, Inc., a prominent professional services firm. The contract supports the Infections and Immunoepidemiology Branch (IIB) and Integrative Tumor Epidemiology Branch (ITEB) of the NCI's Division of Cancer Epidemiology and Genetics (DCEG) with field and biospecimen support services. This work is being conducted under the DCEG Field and Biospecimen Support Services indefinite...
This is a federal contract award to Westat, Inc., a professional services firm based in Rockville, Maryland. The contract was awarded by the National Cancer Institute (NCI), which is part of the U.S. Department of Health and Human Services (HHS). The contract is valued at $3,650,434.16 and is a Definitive Contract with a Cost Plus Fixed Fee pricing type. The contract is for professional services and program management/support, with an ultimate completion date of July 31, 2021. Westat has...
This is a firm fixed-price delivery order awarded to Westat, Inc., a professional services firm, by the National Cancer Institute (NCI) for "OTHER FUNCTIONS/SCIENTIFIC SUPPORT SERVICES: WISER ACTIVITIES". The contract is valued at $70,940.00 and has an ultimate completion date of September 30, 2014. Westat is a prominent provider of research, technical assistance, and program support services to various federal agencies. This award demonstrates Westat's expertise in supporting the...